Dipeptidyl peptidase-3 is associated with severity of liver disease and circulatory complications in patients with cirrhosis.
Andrei Mihai VoiosuSigne WieseJens Peter GoetzeOliver HartmannTheodor VoiosuKarine SantosSøren MøllerPublished in: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals (2022)
DPP3 is a promising marker for portal hypertension and systemic hemodynamic changes in cirrhosis.